Clinical trial
A Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies
NCT00629473 is registered in ClinicalTrials.gov with Celgene as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies
- Lead sponsor
- Celgene
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 31, 2007
- Completion date
- April 30, 2013
- Enrollment
- 86 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancer